Carefusion
Also registered as Carefusion Corporation, Carefusion, Inc.
Country not established FDA establishment FEI 3012410077
- Devices
- 1,039
- Registrations
- FDA
- FDA recalls
- 3124 ongoing
Catalogue
Search and filter all 1,039 devicesShowing 1-50 of 1,039
Company details
- FDA FEI number
- 3012410077
- Address
- 3750 Torrey View Court, San Diego, CA, 92130
FDA recalls
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 16
- 2022 9
- 2023 0
- 2024 0
- 2025 0
- 2026 0
2022
- 1 Aug 2022 Z-1752-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1753-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1754-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1755-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1756-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1757-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1758-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1759-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1760-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
Full distribution text
- 1 Aug 2022 Z-1752-2022 Class II Ongoing Administration set, and extension set product labels list expiration year 2027 but the labels should list expiration year 2025. If expired product is used, the integrity of the product may be compromised, and may result in potential leaks and risk of infection to the patient and healthcare worker.
2021
- 2 Aug 2021 Z-2454-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2454-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Show the 25 most recent of 31 recalls
2021
- 2 Aug 2021 Z-2455-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2456-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2457-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2458-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2459-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2460-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2461-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2462-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2463-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2464-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2465-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2466-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2467-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 2 Aug 2021 Z-2468-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Full distribution text
- 9 Jun 2021 Z-1995-2021 Class II Terminated A portion of a validation lot was inadvertently released to the US Market. The product did not meet the validation testing criteria regarding leakage.
- 2 Aug 2021 Z-2455-2021 Class II Ongoing Needle-free connector valves, either standalone or attached to extension sets, may have issues including difficulty to flush, flow issues, and partial or total occlusions, which could lead to therapy delay. Follow-up activates not required if product has already been used or was safely connected to the female luer of connecting device.
Frequently asked questions
How many devices does CAREFUSION have in the registry?
The registry currently lists 1039 devices for CAREFUSION. Devices recorded under merged duplicate company entries are counted once.
Which registries list CAREFUSION's devices?
Among its 50 most recently registered devices, CAREFUSION has devices listed in FDA GUDID (50 devices).
What risk classes do CAREFUSION's devices fall under?
Among its 50 most recently registered devices, the classes recorded for CAREFUSION's devices are Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for CAREFUSION?
FDA recall records list 31 recalls initiated by CAREFUSION, the most recent initiated on 2022-08-01. 24 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from CAREFUSION in the registry?
The most recently registered devices listed for CAREFUSION include AirLife 4682A, Vmax 23149-001, Somnostar 23586-001 and Infant Flow 11541-102.